New: Clinical trial search, funded by the National Cancer InstituteNew: NCI-funded clinical trial search

After starting semaglutide for presumed MASLD, how often do you recheck ALT?

Ask a clinical question

Answers grounded in the literature and physician expertise.

Related Questions

How do you decide which GLP-1s to prescribe for obesity?

Would you begin semaglutide in a morbidly obese patient with intermittent elevations in ALT (100s) and with significant hepatic steatosis but without significant fibrosis?

Do you start an SGLT-2 inhibitor in decompensated cirrhosis with controlled ascites on diuretics and normal renal function?

About Mednet

A community where doctors find answers to medicine's toughest questions.

Verified, credentialed physicians
45,000+ members across 24 specialties
Free CME and MOC credit

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
TrialMatch
Mobile App

Company

About
Careers
Events
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.